Security Snapshot

KORU Medical Systems, Inc. - Common Stock (KRMD) Institutional Ownership

CUSIP: 759910102

13F Institutional Holders and Ownership History from Q2 2018 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

83

Shares (Excl. Options)

20,897,157

Price

$5.81

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
KRMD on Nasdaq
Shares outstanding
46,785,245
Price per share
$4.34
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
20,897,157
Total reported value
$121,411,724
% of total 13F portfolios
0%
Share change
+109,860
Value change
+$2,305,543
Number of holders
83
Price from insider filings
$4.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • KRMD - KORU Medical Systems, Inc. - Common Stock is tracked under CUSIP 759910102.
  • 83 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 83 to 33 between Q4 2025 and Q1 2026.
  • Reported value moved from $121,411,724 to $19,713,595.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 83 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 759910102?
CUSIP 759910102 identifies KRMD - KORU Medical Systems, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of KORU Medical Systems, Inc. - Common Stock (KRMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Horton Capital Partners, LLC 13% -9.6% $32,673,802 -$3,130,506 5,845,045 -8.7% Joseph M. Manko, Jr. 13 Feb 2026
Topline Capital Management, LLC 8.5% $22,030,268 3,941,014 Topline Capital Management, LLC 31 Dec 2025
First Light Asset Management, LLC 8.3% -22% $21,417,945 -$5,550,194 3,831,475 -21% Mathew P. Arens 31 Dec 2025
BlackRock, Inc. 4.9% -4% $9,903,501 -$228,493 2,292,477 -2.3% BlackRock, Inc. 31 Mar 2026

As of 31 Dec 2025, 83 institutional investors reported holding 20,897,157 shares of KORU Medical Systems, Inc. - Common Stock (KRMD). This represents 45% of the company’s total 46,785,245 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of KORU Medical Systems, Inc. - Common Stock (KRMD) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
First Light Asset Management, LLC 9% 4,210,512 -7% 1.9% $24,463,075
Topline Capital Management, LLC 8.4% 3,941,014 +8% 2.1% $22,897,291
BlackRock, Inc. 5.1% 2,392,711 +12% 0% $13,901,652
VANGUARD GROUP INC 4.7% 2,207,698 +2.9% 0% $12,826,725
GEODE CAPITAL MANAGEMENT, LLC 2.2% 1,022,860 +1.6% 0% $5,944,327
Meros Investment Management, LP 1.7% 782,386 -7.8% 1.8% $4,545,663
Empire Financial Management Company, LLC 1.5% 703,139 -15% 0.89% $4,085,237
Simcoe Capital LLC 1.4% 674,925 0% 3.7% $3,921,314
Archon Capital Management LLC 1.4% 637,660 -8.9% 2.1% $3,704,805
STATE STREET CORP 1.3% 602,645 +33% 0% $3,501,367
MORGAN STANLEY 0.91% 427,026 +28% 0% $2,481,021
NORTHERN TRUST CORP 0.67% 312,798 -8.5% 0% $1,817,357
WHITE PINE CAPITAL LLC 0.47% 221,199 -1.9% 0.35% $1,285,166
ALBION FINANCIAL GROUP /UT 0.46% 216,374 0% 0.08% $1,257,133
Russell Investments Group, Ltd. 0.42% 195,773 +28% 0% $1,137,438
GOLDMAN SACHS GROUP INC 0.36% 169,349 +32% 0% $983,918
Connor, Clark & Lunn Investment Management Ltd. 0.3% 138,512 +18% 0% $804,755
Informed Momentum Co LLC 0.29% 136,716 0.09% $794,320
ROYAL BANK OF CANADA 0.28% 133,004 +8726% 0% $773,000
HighMark Wealth Management LLC 0.26% 120,935 0% 0.29% $702,632
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.26% 120,664 0% 0% $701,058
PNC Financial Services Group, Inc. 0.21% 97,005 +0.01% 0% $563,599
Bank of New York Mellon Corp 0.19% 90,461 -1.1% 0% $525,580
SEI INVESTMENTS CO 0.17% 81,710 0% $474,735
Calamos Advisors LLC 0.17% 80,961 +77% 0% $470,383

Institutional Holders of KORU Medical Systems, Inc. - Common Stock (KRMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,563,256 $19,713,595 +$1,934,066 $4.32 33
2025 Q4 20,897,157 $121,411,724 +$2,305,543 $5.81 83
2025 Q3 20,112,517 $77,043,903 +$2,940,761 $3.83 76
2025 Q2 19,389,863 $69,416,924 +$7,966,852 $3.58 79
2025 Q1 17,446,062 $44,313,166 +$347,421 $2.54 78
2024 Q4 17,181,941 $66,157,164 +$524,457 $3.85 64
2024 Q3 12,774,221 $34,874,519 -$4,229,461 $2.73 54
2024 Q2 14,343,946 $38,010,669 -$11,542,000 $2.65 64
2024 Q1 18,755,095 $44,253,271 +$441,702 $2.36 59
2023 Q4 18,557,345 $45,782,578 +$1,353,136 $2.46 58
2023 Q3 18,002,417 $48,607,090 -$3,528,406 $2.70 55
2023 Q2 18,409,479 $64,998,284 +$4,392,355 $3.45 62
2023 Q1 17,347,333 $73,158,415 +$2,289,339 $4.22 54
2022 Q4 16,656,406 $59,454,859 +$918,278 $3.57 39
2022 Q3 16,333,666 $36,423,000 +$544,988 $2.23 35
2022 Q2 16,081,177 $40,677,000 +$1,407,911 $2.53 32
2022 Q1 15,520,663 $44,688,000 +$466,073 $2.86 32
2021 Q4 26,726,398 $80,175,000 +$55,828 $3.00 40
2021 Q3 25,948,070 $73,954,000 -$5,332,222 $2.85 48
2021 Q2 26,645,194 $123,902,000 +$2,830,375 $4.63 61
2021 Q1 26,050,968 $91,694,886 -$6,576,330 $3.52 71
2020 Q4 27,205,687 $163,776,000 -$15,237,247 $6.02 75
2020 Q3 28,751,554 $207,582,000 -$2,503,748 $7.22 88
2020 Q2 28,867,020 $259,190,431 +$41,937,315 $8.98 89
2020 Q1 24,318,112 $182,361,000 +$15,775,657 $7.50 54
2019 Q4 22,334,896 $145,847,000 +$14,292,123 $6.53 39
2019 Q3 7,180,017 $28,361,000 +$1,147,474 $3.95 1
2019 Q2 6,891,557 $19,847,000 -$14,084 $2.87 2
2019 Q1 6,896,491 $11,035,000 +$53,485 $1.61 2
2018 Q4 6,863,032 $11,324,000 +$11,319,150 $1.64 2
2018 Q3 2,980 $5,000 +$1,592 $1.68 1
2018 Q2 2,031 $3,000 +$3,000 $1.48 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .